{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:50:37Z","timestamp":1774435837918,"version":"3.50.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFC2005500"],"award-info":[{"award-number":["2020YFC2005500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>As adjunctive therapy, puerarin injection has been widely applied for the treatment of unstable angina pectoris (UAP) in China during the past decades. However, the efficacy of puerarin injection as adjunctive therapy for UAP has not been well confirmed. The purpose of this meta-analysis was to summarize the available evidence to estimate the efficacy of puerarin injection in treating UAP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>A systematic review and meta-analysis with subgroup analysis and sensitivity analysis according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) principle were carried out to evaluate the efficacy of puerarin injection as adjunctive therapy in treating UAP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To obtain the published randomized controlled trials (RCTs) on puerarin injection, databases, namely, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chinese Biomedical Literature Database, Sino-Med, PubMed, China Science and Technology Journal Database (VIP), Medline, Google Scholar, Cochrane Library, Chinese Science Citation Database, and Embase were systematically searched until June 2021. In this meta-analysis, Review Manager version 5.3 software and Stata version 12.0 software were employed to analyze the collected data. Based on the methodological quality, years of publications, sample size and dosages, sensitivity analysis, and subgroup analysis were performed. The GRADE assessment was conducted by the software GRADEpro version 3.6 software.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 17 RCTs involving 1,459 patients were included in this meta-analysis. Results indicated that puerarin injection as adjunctive therapy was more superior than conventional Western medicine alone in reducing angina symptoms [risk ratio (RR) = 1.22, 95% CI 1.16 to 1.28, <jats:italic>Z<\/jats:italic> = 8.11, <jats:italic>p<\/jats:italic> &amp;lt; 0.00001] and improving ECG (RR = 1.32, 95% CI 1.20 to 1.44, <jats:italic>Z<\/jats:italic> = 6.00, <jats:italic>p<\/jats:italic> &amp;lt; 0.00001), meanwhile reducing the frequency of angina attack [mean difference (MD) = \u22122.22, 95% CI \u22122.53 to \u22121.90, <jats:italic>Z<\/jats:italic> = 13.97, <jats:italic>p<\/jats:italic> &amp;lt; 0.00001] and the duration of angina attack (MD = \u22122.00, 95% CI \u22122.39 to \u22121.61, <jats:italic>Z<\/jats:italic> = 9.99, <jats:italic>p<\/jats:italic> &amp;lt; 0.00001) for the treatment of UAP. Results from the GRADE assessment suggested that the comprehensive quality of this evidence was low.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This meta-analysis indicated that puerarin injection was more effective than using conventional Western medicine alone in the treatment of UAP. However, because of the low methodological quality of the included RCTs, more evidence was still needed to verify the efficacy of puerarin injection.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.763567","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T05:38:20Z","timestamp":1645681100000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["A Systematic Review and Meta-Analysis on the Efficacy of Puerarin Injection as Adjunctive Therapy for Unstable Angina Pectoris"],"prefix":"10.3389","volume":"9","author":[{"given":"Huikai","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongsheng","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/01.CIR.59.3.607","article-title":"Nomenclature and criteria for diagnosis of ischemic heart disease, the joint international society and federation of cardiology\/world health organization task force on standardization of clinical nomenclature","volume":"59","author":"Bernard","year":"1979","journal-title":"Circulation."},{"key":"B2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.hlc.2017.10.016","article-title":"The efficacy of Danshen injection as adjunctive therapy in treating angina pectoris: a systematic review and meta-analysis","volume":"27","author":"Shao","year":"2018","journal-title":"Heart Lung Circ."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1161\/CIRCULATIONAHA.106.179918","article-title":"Heart disease and stroke statistics-2007 update: a report from the american heart association statistics committee and stroke statistics subcommittee","volume":"115","author":"Rosamond","year":"2007","journal-title":"Circulation."},{"key":"B4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1161\/CIR.0b013e31823a5596","article-title":"ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology foundation\/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation."},{"key":"B5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.phymed.2018.04.044","article-title":"Efficacy and safety of oral Panax notoginseng saponins for unstable angina patients: a meta-analysis and systematic review","volume":"47","author":"Duan","year":"2018","journal-title":"?Phytomedicine."},{"key":"B6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eujim.2019.02.012","article-title":"12 kinds of Chinese medicine injections for acute cerebral infarction: protocol for a systematic review and network meta-analysis","volume":"27","author":"Yu","year":"2019","journal-title":"Eur J Integr Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1080\/14786419.2014.928291","article-title":"Puerarin tuberose: a review on its phytochemical and therapeutic potential","volume":"28","author":"Maji","year":"2014","journal-title":"Nat Prod Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/jcph.96","article-title":"Radix puerariae: an overview of its chemistry, pharmacology, pharmacokinetics and clinical use","volume":"53","author":"Zhang","year":"2013","journal-title":"J Clin Pharmacol."},{"key":"B9","first-page":"55","article-title":"Effects of puerarin on blood pressure and plasma renin activity in spontaneously hypertensive rats","volume":"9","author":"Song","year":"1988","journal-title":"Acta Pharmacol Sin."},{"key":"B10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1875-5364(14)60064-9","article-title":"Progress on the pharmacological research of puerarin: a review","volume":"12","author":"Wei","year":"2014","journal-title":"Chin J Nat Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.12659\/MSM.895362","article-title":"Efficacy of ligustrazine injection as adjunctive therapy for angina pectoris: a systematic review and meta-analysis","volume":"21","author":"Shao","year":"2015","journal-title":"Med Sci Monit."},{"key":"B13","doi-asserted-by":"publisher","first-page":"761722","DOI":"10.3389\/fphar.2021.761722","article-title":"Efficacy of ligustrazine injection as adjunctive therapy in treating acute cerebral infarction: a systematic review and meta-analysis","volume":"12","author":"Shao","year":"2021","journal-title":"Front Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"153879","DOI":"10.1016\/j.phymed.2021.153879","article-title":"Sodium tanshinone IIA sulfonate injection as adjunctive therapy for the treatment of heart failure: a systematic review and meta-analysis","volume":"95","author":"Shao","year":"2022","journal-title":"Phytomedicine."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/01.CIR.102.10.1193","article-title":"ACC\/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations","volume":"102","author":"Braunwald","year":"2000","journal-title":"Circulation."},{"key":"B16","first-page":"409","article-title":"Recommendations for the diagnosis and treatment of unstable angina pectoris","volume":"28","author":"Cardiology","year":"2000","journal-title":"Chin J Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials."},{"key":"B18","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3389\/fphar.2020.00822","article-title":"Efficacy and safety of xueshuantong injection on acute cerebral infarction: clinical evidence and GRADE assessment","volume":"11","author":"Lyu","year":"2020","journal-title":"Front Pharmacol."},{"key":"B19","first-page":"351","article-title":"Effect of puerarin injection on unstable angina pectoris","volume":"1","author":"Cai","year":"2002","journal-title":"Dig World Latest Med Inform."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.6039\/j.issn.1001-0408.2017.12.18","article-title":"Analysis of the clinical observation of puerarin injection for elderly female patients with osteoporosis and unstable angina pectoris","volume":"28","author":"Chen","year":"2017","journal-title":"China Pharm."},{"key":"B21","first-page":"40","article-title":"Application of puerarin in unstable angina pectoris","volume":"10","author":"Fan","year":"2002","journal-title":"J Med Forum."},{"key":"B22","first-page":"257","article-title":"Clinical observation of puerarin nitroglycerin in treatment of unstable angina pectoris","volume":"20","author":"Guo","year":"2006","journal-title":"J Changzhi Med Coll."},{"key":"B23","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3969\/j.issn.1001-7585.2002.07.015","article-title":"Clinical effect of puerarin on unstable angina pectoris","volume":"15","author":"Huang","year":"2002","journal-title":"J Med Theor Prac."},{"key":"B24","first-page":"291","article-title":"Curative effects of puerarin injection on unstable angina pectoris","volume":"26","author":"Liang","year":"2004","journal-title":"J Linyi Med Coll."},{"key":"B25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3760\/cma.j.issn.1674-4756.2003.17.019","article-title":"Effect of puerarin on unstable angina pectoris of coronary heart disease","volume":"30","author":"Li","year":"2003","journal-title":"Cent Plain Med J."},{"key":"B26","first-page":"41","article-title":"Therapeutic effect of puerarin injection on unstable angina pectoris","volume":"6","author":"Liu","year":"2006","journal-title":"J China Prescription Drug."},{"key":"B27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3969\/j.issn.1002-2619.2004.10.051","article-title":"Clinical observation of unstable angina treated by puerarin injection and its effect on oxidized low-density lipoprotein","volume":"26","author":"Meng","year":"2004","journal-title":"Hebei J Tradit Chin Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3969\/j.issn.1001-0408.2002.08.013","article-title":"The cost effectiveness analysis of three schemes in treatment of unstable angina pectoris","volume":"2","author":"Wang","year":"2002","journal-title":"Eval Anal Drug-use Hosp China."},{"key":"B29","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3969\/j.issn.1009-6469.2016.04.057","article-title":"Efficacy of puerarin combined with clopidogrel in the treatment of unstable angina pectoris and its effect on inflammatory factors in patients","volume":"20","author":"Xia","year":"2016","journal-title":"Anhui Med Pharm J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3969\/j.issn.1674-7372.2015.08.028","article-title":"Curative efficacy of puerarin injection combined with fluvastatin in the treatment of elderly patients with unstable angina pectoris and its effects on inflammatory factors","volume":"7","author":"Yang","year":"2015","journal-title":"Chin Front Med Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3870\/j.issn.1004-0781.2000.06.043","article-title":"Puerarin in treating 45 cases of senile unstable angina pectoris","volume":"19","author":"Yao","year":"2000","journal-title":"Her Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3969\/j.issn.1004-583X.2003.11.025","article-title":"Effect of puerarin injection on unstable angina pectoris","volume":"18","author":"Yuan","year":"2003","journal-title":"Clin Focus."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.7501\/j.issn.1674-5515.2017.08.014","article-title":"Clinical study and metabolomics mechanism on puerarin injection in treatment of unstable angina pectoris","volume":"32","author":"Zhang","year":"2017","journal-title":"Drug Clin."},{"key":"B34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3969\/j.issn.1671-4008.2009.04.020","article-title":"Therapeutic effect of puerarin on senile unstable angina pectoris","volume":"26","author":"Zhang","year":"2009","journal-title":"Prac J Med Pharm."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3969\/j.issn.1673-842X.2008.05.001","article-title":"Curative effect of puerarin injection on unstable angina pectoris","volume":"10","author":"Zhang","year":"2008","journal-title":"J Liaoning Univ Tradit Chin Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"107086","DOI":"10.1016\/j.intimp.2020.107086","article-title":"Puerarin protects against myocardial ischemia\/reperfusion injury by inhibiting inflammation and the NLRP3 inflammasome: the role of the SIRT1\/NF-\u03baB pathway","volume":"89","author":"Wang","year":"2020","journal-title":"Int Immunopharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"14577","DOI":"10.3919\/ringe1963.48.93","article-title":"Puerarin injection for treatment of unstable angina pectoris: a meta-analysis and systematic review","volume":"8","author":"Gao","year":"2015","journal-title":"Int J Clin Exp Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11010-011-0746-0","article-title":"Puerarin: a novel antagonist to inward rectifier potassium channel (IK1)","volume":"352","author":"Zhang","year":"2011","journal-title":"Mol Cell Biochem."},{"key":"B39","first-page":"1212","article-title":"Puerarin blocks Na+ current in rat ventricular myocytes","volume":"24","author":"Zhang","year":"2003","journal-title":"Acta Pharmacol Sin."},{"key":"B40","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/ptr.2437","article-title":"The correlation between angiogenesis and abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure, and improvement by puerarin","volume":"22","author":"He","year":"2008","journal-title":"Phytother Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jep.2011.01.055","article-title":"The optimal therapeutic timing and mechanism of puerarin treatment of spinal cord ischemia-reperfusion injury in rats","volume":"134","author":"Tian","year":"2011","journal-title":"J Ethnopharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainresbull.2014.01.001","article-title":"Puerarin blocks the signaling transmission mediated by P2X3 in SG and DRG to relieve myocardial ischemic damage","volume":"101","author":"Liu","year":"2014","journal-title":"Brain Res Bull."},{"key":"B43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/aps.2013.185","article-title":"Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1\/2, p38 and NF-\u03baB pathways","volume":"35","author":"Chen","year":"2014","journal-title":"Acta Pharmacol Sin."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.763567\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T05:38:40Z","timestamp":1645681120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.763567\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":43,"alternative-id":["10.3389\/fcvm.2022.763567"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.763567","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"article-number":"763567"}}